TODD STRATEGY GROUP

Lobbying for GENEOSCOPY, INC. · A life sciences company focused on developing diagnostic tests for gastrointestinal health

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Missouri · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Colorectal Cancer Screening Access. Medicare Quality Measures USPSTF colorectal cancer screening guidelines.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.